| scholarly article | Q13442814 |
| P356 | DOI | 10.1080/14740338.2017.1372421 |
| P698 | PubMed publication ID | 28854831 |
| P50 | author | Manuel Ramos-casals | Q42646201 |
| P2093 | author name string | Pilar Brito-Zerón | |
| Soledad Retamozo | |||
| Belchin Kostov | |||
| Alejandra Flores-Chávez | |||
| Roberto Perez-Alvarez | |||
| Marta Pérez-De-Lis | |||
| P407 | language of work or name | English | Q1860 |
| P577 | publication date | 2017-08-31 | |
| P1433 | published in | Expert Opinion on Drug Safety | Q5421206 |
| P1476 | title | Autoimmune Diseases Induced By Biological Agents. A review of 12731 cases (BIOGEAS Registry). |
| Q55001725 | A New Venue of TNF Targeting. |
| Q55518070 | Anti–NMDAR encephalitis in a patient with Crohn disease receiving adalimumab. |
| Q95277418 | Association Between Tumor Necrosis Factor Inhibitor Exposure and Inflammatory Central Nervous System Events |
| Q64097919 | Biologic Treatments in Interstitial Lung Diseases |
| Q57183819 | Etanercept-induced Crohn's disease in ankylosing spondylitis: a case report and review of the literature |
| Q91801554 | Frequency and distribution of various rheumatic disorders associated with checkpoint inhibitor therapy |
| Q56877478 | Ipilimumab treatment associated with myasthenic crises and unfavorable disease course |
| Q91801513 | Management of rheumatic complications of ICI therapy: a rheumatology viewpoint |
| Q56893186 | Musculoskeletal and Rheumatic Diseases Induced by Immune Checkpoint Inhibitors: A Review of the Literature |
| Q52564720 | Nephritis, cerebritis, and myositis after adalimumab therapy in a patient with rheumatoid arthritis: a case report. |
| Q91906829 | Panax ginseng: a candidate herbal medicine for autoimmune disease |
| Q88930539 | Thrombosis and Anti-phospholipid Syndrome: a 5-Year Update on Treatment |
Search more.